Jim Simons Kala Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.25 - $11.7 $20,300 - $950,040	81,200 Added 22.83%	436,800 $97,000
Q2 2022 Aug 12, 2022	BUY	$0.3 - $1.31 $28,170 - $123,009	93,900 Added 35.88%	355,600 $107,000
Q1 2022 May 13, 2022	BUY	$0.61 - $1.84 $82,838 - $249,872	135,800 Added 107.86%	261,700 $361,000
Q4 2021 Feb 11, 2022	SELL	$1.16 - $2.74 $46,632 - $110,148	-40,200 Reduced 24.2%	125,900 $152,000
Q3 2021 Nov 12, 2021	BUY	$2.62 - $5.43 $435,182 - $901,923	166,100 New	166,100 $435,000
Q1 2021 May 13, 2021	SELL	$6.24 - $9.58 $602,259 - $924,623	-96,516 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$6.28 - $8.79 $606,120 - $848,375	96,516 New	96,516 $654,000
Q3 2020 Nov 13, 2020	SELL	$7.5 - $11.11 $128,812 - $190,814	-17,175 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$8.33 - $13.79 $827,202 - $1.37 Million	-99,304 Reduced 85.25%	17,175 $181,000
Q1 2020 May 14, 2020	BUY	$3.83 - $8.79 $446,114 - $1.02 Million	116,479 New	116,479 $1.02 Million
Q3 2019 Nov 13, 2019	SELL	$3.57 - $6.58 $144,585 - $266,490	-40,500 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$4.93 - $8.8 $352,495 - $629,200	-71,500 Reduced 63.84%	40,500 $258,000
Q1 2019 May 14, 2019	SELL	$5.19 - $8.97 $929,326 - $1.61 Million	-179,061 Reduced 61.52%	112,000 $926,000
Q4 2018 Feb 13, 2019	BUY	$4.29 - $9.94 $1.25 Million - $2.89 Million	291,061 New	291,061 $1.42 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.05M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.